IRCT2013102215113N1已完成未知
Effect of oral ibuprofen for patent ductus arteriosus closure in infants
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 3 years（—）
- 性别
- All
入选标准
- •term infants (gestational age 37-42 weeks); Life Age = 3 days of patent ductus arteriosus by echocardiography ; Proof of completion of an informed consent form
- •Exclusion criteria: There is a reluctance to participate in the study ; Contraindications including ibuprofen creatinine> 8/1; platelet count less than 50,000 ;active gastrointestinal hemorrhage or intraventricular hemorrhage (confirmed by ultrasound); Antrkvlyt necrosis and sepsis; patent ductus arteriosus associated with other disorders; such as TORCH (intrauterine infection).
排除标准
- 未提供
研究者
相似试验
Unknown
1 期
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature InfantsExtremely Premature InfantsPDAOral IbuprofenIV IbuprofenNCT01149564China Medical University Hospital70
已完成
2 期
High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm InfantDuctus Arteriosus, PatentNCT01243996University of Florence70
Unknown
不适用
Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight InfantsOral Ibuprofen Prophylaxis in Very Low Birth Weight InfantsNCT01400737Zekai Tahir Burak Women's Health Research and Education Hospital200
已完成
2 期
Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm InfantsPatent Ductus Arteriosus After Premature BirthPatent Ductus Arteriosus Conservative ManagementNCT05493540Nada Youssef80
终止
不适用
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) ClosurePrematurityPatent Ductus ArteriosusNCT00833365University of Utah15